Stocks · US SMMT XNAS

Summit Therapeutics Inc. Common Stock

$17.31 +0.23% Market cap $13.8B 2026-10-06 close

📈 Chart & live quote

Data as of 2026-10-06 · Linked from 0 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-06 basis

P/E—

P/B21.87x

P/S—

EPS$-1.07

ROE-135.90%

ROA-113.82%

Dividend yield0.00%

EV/EBITDA—

Debt/Equity0.00

Free cash flow$-460M

Returns and 52-week range

1W+5.61%

1M-1.68%

3M+10.33%

6M-9.94%

1Y-19.23%

YTD-1.20%

52W high$29.23

52W low$12.07

From 52W high-40.78%

Company

HeadquartersMiami, FL

Employees265

Listed2015-03-05

Websitewww.smmttx.com

SECFilings

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.